表紙
市場調查報告書

數位病理市場趨勢分析、競爭市場佔有率、預測 (2016-2026年):各產品、類型、用途、終端用戶、地區

Digital Pathology Market by Product, Type, By Application, By End-User By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26

出版商 Blueweave Consulting & Research Private Limited 商品編碼 948289
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
數位病理市場趨勢分析、競爭市場佔有率、預測 (2016-2026年):各產品、類型、用途、終端用戶、地區 Digital Pathology Market by Product, Type, By Application, By End-User By Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26
出版日期: 2020年04月01日內容資訊: 英文 177 Pages
簡介

全球數位病理市場規模,預計從2019年的5億2000萬美元,到2026年成為10億6000萬美元的規模,在2020年∼2026年的預測期間內,以12.6%的年複合成長率成長。疾病診斷,簡單的體檢,醫療產業的數位化的趨勢中數位病理的需求高漲,促進數位病理市場成長。尤其是新興各國的遠程病理學的使用增加,預期生出市場的新機會。

本報告提供全球數位病理市場相關調查,目前市場趨勢,對市場的影響要素,各市場區隔、各地區的市場分析與預測,並提供主要企業簡介等資訊。

第1章 調查組成架構

第2章 調查手法

第3章 摘要整理

第4章 全球數位病理分析

  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術形勢/近幾年的開發
  • 法律規範
  • 企業的市場佔有率分析
  • 波特的五力分析

第5章 全球數位病理市場概要

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
      • 軟體
      • 設備
      • 通信系統
      • 存儲系統
    • 各類型
      • 人的病理學
      • 獸醫病理學
    • 各應用領域
      • tele協商
      • 疾病診斷
      • 藥物研發
      • 訓練與教育
      • 其他
    • 各終端用戶
      • 醫藥品&生物科技企業
      • 醫院& 索引實驗室
      • 大學&研究機關
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲

第6章 北美的數位病理市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國
      • 美國
      • 加拿大

第7章 歐洲的數位病理市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲

第8章 亞太地區的數位病理市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區

第9章 南美的數位病理市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他南美國家

第10章 中東及非洲的數位病理市場

  • 市場規模、預測:以金額為準
    • 以金額為準
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各應用領域
    • 各終端用戶
    • 各國
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 其他中東和非洲

第11章 企業簡介 (公司概要,財務矩陣,產品形勢,主要人物,主要競爭企業,聯絡原住所,及策略性展望)

  • Leica Biosystems
  • Ventana Medical Systems
  • HAMAMATSU PHOTONICS
  • 3DHISTECH
  • Koninklijke Philips
  • Roche
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm
  • Corista
  • Indica Labs
  • Objective Pathology Services
  • Olympus Corporation
  • Mikroscan Technologies
  • Digipath, Inc.
  • TRIBVN Healthcare
  • Danaher
  • NIKON
  • 其他有潛力的企業
目錄
Product Code: BWC20020

Title:
Digital Pathology Market by Product (Software, Device, Communication Systems, Storage Systems), Type (Human Pathology, Veterinary Pathology), By Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training and Education, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals, and Reference Laboratories, Academic & Research Institutes) By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-26.

The Global Digital Pathology Market reached USD 0.52 Billion in 2019 and projected to witness market size of USD 1.06 Billion by 2026, at a CAGR 12.6% during the forecast period 2020-2026. Rising demand for digital pathology in disease diagnosis, easy consultation, and the digitalization trend in the medical industry boost the growth of the digital pathology market.

The growing use of telepathology, especially in developing economies are expected to generate new opportunities in the market. Technological advancements such as computerization, digital imaging, multiple fiberoptic communications, and robotic light microscopy are some of the major factors leading to the adoption of digital pathology.

Moreover, the introduction of cloud-based technology allowing the storage of digital slides along with secure access to pathologists anticipated to serve as a prospective growth driver for the market. The increasing government attention to implement advanced systems for improved efficiency and quick response is a contributing factor. Combined with these factors, the expanding patient pool, delays in radiography diagnostics owing to high waiting time are expected to provide a favorable environment for the adoption of digital pathology systems over the forecast period.

Artificial Intelligence with digital pathology stimulate the market with significant growth during the forecast period

Digital pathology systems are gaining popularity among pathologists owing to its operational efficiency and increasing need for integrated healthcare facilities. A combination of Artificial Intelligence (AI) technologies with digital pathology is a potential growth factor. Investors are ready to capitalize hugely in start-ups attempting to adopt artificial intelligence. Technology experts claim that machine learning and other sophisticated technologies can assist pathologists, making them more detailed in their analysis. Digital pathology market trends such as the integration of AI into digital pathology systems is expected to influence market growth. The adoption of AI in digital pathology offers efficient image recognition and automated diagnostic capabilities. Vendors are emphasizing on developing AI-powered software platforms to extend applications in digital pathology workflows such as automation in result interpretations, image analytics, and decision making. Automated applications will assist to overcome the challenges associated with the lack of trained professionals. To fulfill this growing demand, vendors are concentrating on the continuous development of AI platforms and applications by strategic initiatives.

North American regional segment expected to witness lucrative growth in global Digital Pathology market

North America is anticipated to hold the largest share in the global digital pathology market owing to accessibility of expertise, well-developed healthcare infrastructure, and increasing emphasis on digitization of diagnostic procedures. The technological advancements by leading market players are anticipated to augment the adoption of digital pathology systems in North America during the forecast period. Further, the increasing trends of machine learning and artificial intelligence in the region expected to drive the implementation of the global digital pathology market. Factors such as accessibility of expertise, well-developed healthcare infrastructure, and increasing focus on digitization of diagnostic procedures are contributing to the growth of the digital pathology in the region.

The device product segment is anticipated to dominate the digital pathology market

Based on the product, the device segment is expected to dominate the market as the devices can perform repeated data analysis across experiments and produce high-resolution images. Moreover, the rising use of scanners in pathology labs and increasing R&D related to applications such as slide managers is expected to boost the adoption of this technology during the forecast period. Growing demand for online storage system is further fueling the growth. The benefits such as improved productivity, cost reduction, and better patient outcome along with data reliability and Image Lifecycle Management (ILM) are projected to drive the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1.Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1.Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
    • 2.3.1.Secondary Research
    • 2.3.2.Primary Research
  • 2.4. Breakdown of Primary Research Respondents
  • 2.5. Market Size Estimation
  • 2.6. Assumption For The Study
  • 2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Digital Pathology Insights

  • 4.1. DROC Analysis
    • 4.1.1.Growth Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges
  • 4.2. Technological Landscape/Recent Developments
  • 4.3. Regulatory Framework
  • 4.4. Company Market Share Analysis,2019
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1.Bargaining Power of Suppliers
    • 4.5.2.Bargaining Power of Buyers
    • 4.5.3.Threat of New Entrants
    • 4.5.4.Threat of Substitutes
    • 4.5.5.Intensity of Rivalry

5. Global Digital Pathology Market Overview

  • 5.1. Market Size & Forecast By Value, 2016-2026
    • 5.1.1.By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Software
      • 5.2.1.2. Device
      • 5.2.1.3. Communication Systems
      • 5.2.1.4. Storage Systems
    • 5.2.2. By Type
      • 5.2.2.1. Human Pathology
      • 5.2.2.2. Veterinary Pathology
    • 5.2.3. By Application
      • 5.2.3.1. Teleconsultation
      • 5.2.3.2. Disease Diagnosis
      • 5.2.3.3. Drug Discovery
      • 5.2.3.4. Training and Education
      • 5.2.3.5. Others
    • 5.2.4. By End-User
      • 5.2.4.1. Pharmaceutical & Biotechnology Companies
      • 5.2.4.2. Hospitals and Reference Laboratories
      • 5.2.4.3. Academic & Research Institutes
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. Latin America
      • 5.2.5.5. Middle East & Africa

6. North America Digital Pathology Market

  • 6.1. Market Size & Forecast By Value, 2016-2026
    • 6.1.1.By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1.By Product
    • 6.2.2.By Type
    • 6.2.3.By Application
    • 6.2.4.By End-User
    • 6.2.5.By Country
      • 6.2.5.1. United States
      • 6.2.5.2. Canada

7. Europe Digital Pathology Market

  • 7.1. Market Size & Forecast By Value, 2016-2026
    • 7.1.1.By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1.By Product
    • 7.2.2.By Type
    • 7.2.3.By Application
    • 7.2.4.By End-User
    • 7.2.5.By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. United Kingdom
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Spain
      • 7.2.5.6. Rest of Europe

8. Asia Pacific Digital Pathology Market

  • 8.1. Market Size & Forecast By Value, 2016-2026
    • 8.1.1.By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1.By Product
    • 8.2.2.By Type
    • 8.2.3.By Application
    • 8.2.4.By End-User
    • 8.2.5.By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Digital Pathology Market

  • 9.1. Market Size & Forecast By Value, 2016-2026
    • 9.1.1.By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1.By Product
    • 9.2.2.By Type
    • 9.2.3.By Application
    • 9.2.4.By End-User
    • 9.2.5.By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Argentina
      • 9.2.5.4. Rest of Latin America

10. Middle East & Africa Digital Pathology Market

  • 10.1. Market Size & Forecast By Value, 2016-2026
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of Middle East and Africa

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, and Contact Address)*

  • 11.1. Leica Biosystems
  • 11.2. Ventana Medical Systems
  • 11.3. Hamamatsu Photonics
  • 11.4. 3DHISTECH
  • 11.5. Koninklijke Philips
  • 11.6. Roche
  • 11.7. Apollo Enterprise Imaging
  • 11.8. XIFIN
  • 11.9. Huron Digital Pathology
  • 11.10. Visiopharm
  • 11.11. Corista
  • 11.12. Indica Labs
  • 11.13. Objective Pathology Services
  • 11.14. Olympus Corporation
  • 11.15. Mikroscan Technologies
  • 11.16. Digipath, Inc.
  • 11.17. TRIBVN Healthcare
  • 11.18. Danaher
  • 11.19. Nikon Corporation
  • 11.20. Other Prominent Players